Erowid.org: Erowid Reference 7306 : Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients : Laczi F, Valkusz Z, Lászlo FA, Wagner A, Járdánházy T, Szász A, Szilárd J, Telegdy G

Erowid References Database

Laczi F, Valkusz Z, Lászlo FA, Wagner A, Járdánházy T, Szász A, Szilárd J, Telegdy G. “Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients”. Psychoneuroendocrinology. 1982;7(2-3):185-93. <a name="ref">Laczi F, Valkusz Z, Lászlo FA, Wagner A, Járdánházy T, Szász A, Szilárd J, Telegdy G.</a> <a href="/references/7306">"Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients"</a> <i>Psychoneuroendocrinology</i>. 1982;7(2-3):185-93.
Show Articles by Laczi F Valkusz Z Lászlo FA Wagner A Járdánházy T Szász A Szilárd J Telegdy G Article IDs Erowid RefID: 7306 PubMedID: 7178372 Collections Hofmann Collection MDMA Collection All References	Abstract Central diabetes insipidus (DI) patients showed impairments in short- and long-term memory functions, but not in attention and concentration, as compared to healthy individuals. A single i.m. injection or sub-chronic intranasal administration of either lysine-vasopressin (LVP) or 1-deamino-8-D-arginine-vasopressin (DDAVP) normalized the disturbed memory functions in DI patients. These peptides also improved memory functions in healthy individuals.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]